Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $240
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Patrick Moley has maintained an Overweight rating on CME Group (NASDAQ:CME) and raised the price target from $225 to $240.
October 08, 2024 | 11:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has reaffirmed its Overweight rating on CME Group and increased the price target to $240, indicating a positive outlook.
The increase in price target from $225 to $240 by Piper Sandler suggests a positive outlook for CME Group, likely leading to a short-term price increase. The Overweight rating indicates confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100